3M™ Steri-Strip™ C1544Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 30707387022830), received between Apr 16, 2019 and Apr 16, 2019 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryApr 16, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  A CONSUMER REPORTED 3M¿ STERI-STRIP¿ COMPOUND BENZOIN TINCTURE AND 3M¿ R1547 REINFORCED STERI-STRIP¿ SKIN CLOSURES WERE APPLIED TO SEVEN PUNCTURE SITES ON HIS LEG FOLLOWING VARICOSE VEIN SURGERY. ONE WEEK FOLLOWING THE SURGERY HE HAD A FOLLOW-UP APPOINTMENT AND REDNESS WAS NOTED AT ALL SEVEN SITES. HE WAS REPORTEDLY GIVEN A RX FOR TRIAMCINOLONE ACETONIDE CREAM FOR TREATMENT. HE USED THE CREAM FOR THREE DAYS AND REPORTEDLY BROKE OUT IN A BODY RASH. HE WAS SEEN BY HIS SURGEON AND THE TRIAMCINOLONE ACETONIDE CREAM WAS DISCONTINUED. HIS SURGEON PRESCRIBED ORAL METHYLPREDNISOLONE. THE CONSUMER REPORTEDLY TOOK THE METHYLPREDNISOLONE FOR THREE DAYS AND WENT TO THE ER DUE TO FREQUENT URINATION. THE METHYLPREDNISOLONE WAS DISCONTINUED. THE CONSUMER CONSULTED AN ALLERGIST THE FOLLOWING DAY DUE TO THE UNRESOLVED BODY RASH AND WAS DIAGNOSED WITH CONTACT DERMATITIS. HE WAS REPORTEDLY TREATED WITH AN UNSPECIFIED RX CREAM.

  Patient problems: Erythema; Rash

  MAUDE report 8518797 ↗